Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,70116,720 of 20,252 grants

Active NON-SBIR/STTR RPGS
NCI Pediatric In Vivo Testing Program: Neuroblastoma
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2021 – 2026

Project Summary Children with disseminated neuroblastoma have a very high risk of treatment failure and death despite receiving intensified chemotherapy, radiation therapy and immu...

$7.13M
USD
Active NON-SBIR/STTR RPGS
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE Mayo Clinic Jacksonville United States 2021 – 2026

Project Abstract Lung cancer is the number one cause of cancer death in the United States. Non-small cell lung cancer (NSCLC), which accounts for the majority (80%) of lung cancer...

$3.4M
USD
Active NON-SBIR/STTR RPGS
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

PROJECT SUMMARY Tumor heterogeneity is the main cause of resistance to current chemotherapy drugs as well as metastasis development, leading to patients' death. Within the sam...

$3.26M
USD
Active NON-SBIR/STTR RPGS
Urine based circulating tumor DNA analysis
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

ABSTRACT Urine is an underappreciated source for systemic circulating tumor DNA in patients with non-genitourinary cancers. Based on recent data suggesting that blood-based HPV DNA...

$4.32M
USD
Active NON-SBIR/STTR RPGS
Regulatory T cells in cancer therapy
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2026

Project Summary Extensive studies have been conducted to define the development, conversion, stability, and regulatory mechanisms of CD4+Foxp3+ regulatory T cells (Tregs) in homeos...

$6.15M
USD
Completed NON-SBIR/STTR RPGS
Dynamic prediction incorporating time-varying covariates for the onset of breast cancer
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2025

PROJECT SUMMARY Accurate assessment of risk is a top priority in oncology due to the population burden of cancer. Breast cancer is the leading cancer diagnosis among women worldwid...

$3.43M
USD
Completed OTHER RESEARCH-RELATED
Investigating apoptotic priming as a determinant of sensitivity to leukemia-directed therapies
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is a lethal blood cancer characterized by a clonal expansion of precursor blood- forming cells. Intensive chemotherapy has bee...

$2.55M
USD
Completed NON-SBIR/STTR RPGS
Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2025

PROJECT SUMMARY / ABSTRACT Following treatment for early-stage cancer, most survivors fear the possibility of a recurrence. While mild and intermittent for many, these fears become...

$6.18M
USD
Active NON-SBIR/STTR RPGS
Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural Hypothesis
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT As the leading cause of cancer death, lung cancer represents the most significant cancer-related public health challenge in the United States. Although low...

$6.15M
USD
Completed TRAINING, INDIVIDUAL
The oncogenic functions of Neuropilin-1 in the glioblastoma tumor microenvironment
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2025

Abstract Glioblastoma (GB) is the most common primary tumor of the central nervous system (CNS) in adults. Despite aggressive surgery, radiation, and chemotherapy, median survival...

$539.7K
USD
Active NON-SBIR/STTR RPGS
Impact of Host NF-kB Signaling in Radiation Therapy
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

PROJECT SUMMARY / ABSTRACT Investigation of cytoplasmic-to-nuclear (C→N) NF-κB signaling pathways induced by various cell surface receptors has significantly expanded the knowledge...

$3.58M
USD
Active TRAINING, INDIVIDUAL
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2026

Project Summary/Abstract Programmed cell death 1 (PD-1) and its ligands, PD-L1 and PD-L2, are highly expressed in human and murine thymus. Despite this knowledge, the function of t...

$539.7K
USD
Active NON-SBIR/STTR RPGS
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2026

Prostate cancer is characterized by large genomic rearrangements and deletions. We show that the genes CHD1 and MAP3K7 are co-deleted in ERG translocation negative prostate cancer....

$3.72M
USD
Active NON-SBIR/STTR RPGS
Improving pediatric brain tumor treatments using FLASH radiotherapy
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2027

PROJECT SUMMARY Our R01 application entitled, “Improving pediatric brain tumor treatments using FLASH radiotherapy” is focused on translating a novel irradiation modality into clin...

$1.72M
USD
Completed TRAINING, INDIVIDUAL
In vivo characterization of keratinocytes in the melanoma microenvironment
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2025

PROJECT SUMMARY Melanoma is the most lethal of skin cancers, with progression to local invasion and metastasis leading to poor patient outcomes, highlighting the need for better un...

$539.7K
USD
Active NON-SBIR/STTR RPGS
Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2026

Abstract Acute lymphoblastic leukemia (ALL) is the most common cancer in children, with T-cell ALL accounting for 15% of cases. T-ALL in children is associated with aggressive clin...

$5.69M
USD
Active NON-SBIR/STTR RPGS
Novel DNA damage response therapeutics targeting replication protein A
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

Novel DNA damage response therapeutics targeting replication protein A Abstract The DNA damage response (DDR) is now considered a tractable pathway to target for cancer therapy. Th...

$4.67M
USD
Active NON-SBIR/STTR RPGS
A pro-metastatic secretory pathway activated by p53 loss in lung cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Cancer cells are embedded in a protective and nourishing “niche”, an environment that cancer cells create by secreting proteins into their surroundings. Because cancer cells depend...

$5.3M
USD
Active NON-SBIR/STTR RPGS
Rational in situ programming of cancer vaccine-responding T-cell clones
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2021 – 2026

Project Summary Currently no method exists that would allow physicians to rapidly and reliably establish T-cell immunity against tumor antigens. Bioinformatics tools can predict an...

$4.5M
USD
Active OTHER RESEARCH-RELATED
Defining PARP Inhibitor Response and Resistance in Prostate Cancer
NATIONAL CANCER INSTITUTE University of California At Davis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The objective of this K01 award is to promote the development of Dr. Alan Lombard into an independent prostate cancer researcher. The proposed project will...

$1.67M
USD